VISTAGEN THERAPEUTICS, INC. Increase (Decrease) in Deposits Outstanding
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Increase (Decrease) in Deposits Outstanding of $0 for the 12-month period ending 2023-03-31, per its 10-K filed 2023-06-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDepositsOutstanding · last filed 2023-06-28
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in deposits outstanding for the quarter ending 2022-03-31 was $0.00.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in deposits outstanding for the quarter ending 2021-03-31 was $0.00.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in deposits outstanding for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in deposits outstanding for fiscal 2022 was $53.10K.
- VISTAGEN THERAPEUTICS, INC. increase (decrease) in deposits outstanding for fiscal 2021 was $0.00.
| Period end | Increase (Decrease) in Deposits Outstanding 3 month | Increase (Decrease) in Deposits Outstanding 9 month | Increase (Decrease) in Deposits Outstanding 12 month |
|---|---|---|---|
| 2023-03-31 | $0.00 10-K · filed 2023-06-28 | ||
| 2022-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-28 | $53.10K 10-K · filed 2023-06-28 | |
| 2021-12-31 | $53.10K 10-Q · filed 2022-02-10 | ||
| 2021-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-23 | $0.00 10-K · filed 2022-06-23 | |
| 2020-12-31 | $0.00 10-Q · filed 2022-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |